![Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio](https://journals.asm.org/cms/10.1128/mbio.00099-22/asset/436f63da-2f4b-48a5-8830-b18e77712537/assets/images/medium/mbio.00099-22-f003.gif)
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio
![SARS-CoV-2, strain hCoV-19/Italy/LAZ-INMI-642isl/2021, clade G, lineage B.1.617.1, VUM (former VOI Kappa) | EVAg SARS-CoV-2, strain hCoV-19/Italy/LAZ-INMI-642isl/2021, clade G, lineage B.1.617.1, VUM (former VOI Kappa) | EVAg](https://cdn.european-virus-archive.com/sites/default/files/default_images/VirusProduct_381_0.jpg)
SARS-CoV-2, strain hCoV-19/Italy/LAZ-INMI-642isl/2021, clade G, lineage B.1.617.1, VUM (former VOI Kappa) | EVAg
![SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci](https://www.prosci-inc.com/wp-content/uploads/2021/12/SARS-CoV-2-COVID-19-full-length-Spike-S1-Kappa-India-Dec-2020-B-1-617-1-Variant-Recombinant-Protein_picture_21-823.jpg)
SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci
![Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing | Experimental & Molecular Medicine Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing | Experimental & Molecular Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs12276-021-00691-y/MediaObjects/12276_2021_691_Fig1_HTML.png)
Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing | Experimental & Molecular Medicine
![DNA Explainer: Kappa variant of COVID-19 - Know all about its mutations, symptoms and vaccine efficacy DNA Explainer: Kappa variant of COVID-19 - Know all about its mutations, symptoms and vaccine efficacy](https://cdn.dnaindia.com/sites/default/files/2021/07/09/984384-kappa-variant-covid-19.jpg?im=FitAndFill=(1200,900))
DNA Explainer: Kappa variant of COVID-19 - Know all about its mutations, symptoms and vaccine efficacy
![Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41421-021-00347-1/MediaObjects/41421_2021_347_Fig1_HTML.png)
Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery
![Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission - ScienceDirect Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1931312822000427-fx1.jpg)
Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission - ScienceDirect
![Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio](https://journals.asm.org/cms/10.1128/mbio.00099-22/asset/c355a0b9-458b-4bbe-880e-f48e46e35db6/assets/images/medium/mbio.00099-22-f005.gif)